Does MEROPENEM Cause Hepatic cytolysis? 137 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 137 reports of Hepatic cytolysis have been filed in association with MEROPENEM (Meropenem). This represents 1.0% of all adverse event reports for MEROPENEM.
137
Reports of Hepatic cytolysis with MEROPENEM
1.0%
of all MEROPENEM reports
0
Deaths
75
Hospitalizations
How Dangerous Is Hepatic cytolysis From MEROPENEM?
Of the 137 reports, 75 (54.7%) required hospitalization, and 14 (10.2%) were considered life-threatening.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEROPENEM. However, 137 reports have been filed with the FAERS database.
What Other Side Effects Does MEROPENEM Cause?
Drug ineffective (2,802)
Off label use (1,572)
Condition aggravated (706)
Pyrexia (669)
Multiple organ dysfunction syndrome (655)
Drug reaction with eosinophilia and systemic symptoms (626)
Septic shock (613)
Drug resistance (539)
Acute kidney injury (522)
Rash (437)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which MEROPENEM Alternatives Have Lower Hepatic cytolysis Risk?
MEROPENEM vs MEROPENEM ANHYDROUS
MEROPENEM vs MESALAMINE
MEROPENEM vs MESNA
MEROPENEM vs METAMIZOLE
MEROPENEM vs METARAMINOL